Cargando…
The receptor RAGE: Bridging inflammation and cancer
The receptor for advanced glycation end products (RAGE) is a single transmembrane receptor of the immunoglobulin superfamily that is mainly expressed on immune cells, neurons, activated endothelial and vascular smooth muscle cells, bone forming cells, and a variety of cancer cells. RAGE is a multifu...
Autores principales: | Riehl, Astrid, Németh, Julia, Angel, Peter, Hess, Jochen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2690588/ https://www.ncbi.nlm.nih.gov/pubmed/19426472 http://dx.doi.org/10.1186/1478-811X-7-12 |
Ejemplares similares
-
RAGE signaling sustains inflammation and promotes tumor development
por: Gebhardt, Christoffer, et al.
Publicado: (2008) -
Identification of the Rage-dependent gene regulatory network in a mouse model of skin inflammation
por: Riehl, Astrid, et al.
Publicado: (2010) -
RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation
por: Sparvero, Louis J, et al.
Publicado: (2009) -
Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis
por: Bopp, Christian, et al.
Publicado: (2008) -
Role and Mechanisms of RAGE-Ligand Complexes and RAGE-Inhibitors in Cancer Progression
por: El-Far, Ali H., et al.
Publicado: (2020)